Thiourea derivatives, methods of their preparation and their use in neutron capture therapy of malignant melanoma

Patent · 04 June 1991

OSTI ID:7273838

Gabel, D

The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy. No Drawings

• DOE Contract Number: AC02-76CH00016
• Assignee: Dept. of Energy, Washington, DC (United States)
• Patent Number(s): US 5021572; A
• Application Number: PPN: US 7-302289
• OSTI ID: 7273838
• Country of Publication: United States
• Language: English

Related Subjects

550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIMETABOLITES
ANTITHYROID DRUGS
AZINES
BORON
CARCINOMAS
CHEMICAL PREPARATION
DISEASES
DRUGS
ELEMENTS
EPITHELIOMAS
HETEROCYCLIC COMPOUNDS
HORMONE ANTAGONISTS
HYDROXY COMPOUNDS
LABELLED COMPOUNDS
LABELLING
MEDICINE
MELANOMAS
NEOPLASMS
NEUTRON CAPTURE THERAPY
NEUTRON THERAPY
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANIC SULFUR COMPOUNDS
PYRIMIDINES
RADIOLOGY
RADIOPHARMACEUTICALS
RADIOTHERAPY
SEMIMETALS
SYNTHESIS
THERAPY
THIOLS
THIOURACIL
UPTAKE
URACILS